Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

BioCorRx (BICX) Inventory (2025)

BioCorRx (BICX) has disclosed Inventory for 1 consecutive years, with $143425.0 as the latest value for Q4 2025.

Quarterly Inventory changed N/A to $143425.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143425.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $143425.0 for FY2025, N/A changed from the prior year.
Inventory hit $143425.0 in Q4 2025 for BioCorRx, up from $133597.0 in the prior quarter.
In the past five years, Inventory ranged from a high of $143425.0 in Q4 2025 to a low of $133597.0 in Q1 2025.